Understanding microRNA genetic switches that control tumour growth may reveal new drug targets for low grade glioma in children.
Professor Denise Sheer and her team at Queen Mary University, London, hope to develop new drugs which target brain tumour cells without damaging surrounding tissue.
The researchers are focusing on low grade childhood brain tumours called gliomas. Gliomas are often inoperable because of their location in the brain and can become more aggressive over time.
Professor Sheer's team is looking at the role of molecules called microRNAs, which play an important role in controlling which genes are switched on and off within a cell.
They want to find out whether the pattern of microRNAs found in low grade glioma cells is different from that in normal cells, and if so whether that pattern is linked to tumour growth.
Positive results would bring them one step closer to developing a drug that targets glioma cells, based on their pattern of microRNAs, but leaves healthy tissue unharmed.
Gliomas are formed from cells called glial cells, which are involved in supporting and protecting nerve cells within the brain. Gliomas account for the majority of childhood brain tumours and new treatments are needed urgently.
Research is the only way we will discover kinder, more effective treatments and, ultimately, stamp out brain tumours – for good! However, brain tumours are complex and research in to them takes a great deal of time and money.
Across the UK, over 100,000 families are facing the overwhelming diagnosis of a brain tumour and it is only through the generosity of people like you can we continue to help them.
But, by setting up a regular gift – as little as £2 per month - you can ensure that families no longer face this destructive disease.